Gastric Cancer Diagnostics Market Report: Market Size & Forecast 2026

Gastric cancer remains one of the most prevalent cancers globally, with over 1 million new cases diagnosed annually, creating sustained demand for diagnostic services across healthcare systems. The diagnostics market encompasses a spectrum of technologies from conventional endoscopy and histopathology to advanced molecular and genetic testing platforms. Early and accurate detection is critical, as gastric cancer outcomes improve significantly when identified at treatable stages, driving investment in screening and diagnostic capacity.

• •Endoscopy with biopsy continues to serve as the primary diagnostic method for initial detection and tissue characterization
• •Molecular diagnostics are increasingly utilized to identify biomarkers including HER2 overexpression, microsatellite instability, and PD-L1 expression
• •Liquid biopsy approaches analyzing circulating tumor DNA represent an emerging non-invasive diagnostic and monitoring tool

Rising global incidence of gastric cancer, influenced by aging demographics, dietary patterns, and Helicobacter pylori infection prevalence, forms the foundation of market expansion. The proliferation of targeted therapies and immunotherapies has created heightened demand for companion diagnostic tests that identify patients most likely to benefit from specific treatments. Additionally, expanded screening initiatives and growing healthcare access in developing regions are enlarging the addressable patient population requiring diagnostic services.

• •Global gastric cancer incidence continues to rise, particularly in East Asia, Eastern Europe, and Latin America
• •Adoption of precision oncology approaches has increased demand for comprehensive biomarker profiling to guide treatment decisions
• •Technological advances in next-generation sequencing and automated immunoassay platforms are improving test accuracy while reducing costs

The market is organized by test type, product category, and geography, with in-vitro diagnostic tests and endoscopic equipment representing the largest segments by revenue. Asia-Pacific commands the dominant regional share due to the highest global burden of gastric cancer, particularly in China, Japan, and South Korea, where organized screening programs are well-established. North America and Europe constitute mature markets characterized by advanced diagnostic infrastructure, while Latin America, the Middle East, and Southeast Asia represent emerging growth regions as healthcare systems modernize.

• •In-vitro diagnostics encompassing immunoassays, molecular tests, and genetic analysis represent the fastest-growing segment
• •Asia-Pacific accounts for the largest regional market share, supported by high disease prevalence and national screening initiatives
• •North America and Europe maintain significant market positions with strong adoption of advanced molecular diagnostic technologies

What are the recent trends and outlook?

The market is positioned for sustained growth through 2030, supported by continued technological innovation and expanding clinical applications of advanced diagnostics. Integration of artificial intelligence in endoscopic imaging and digital pathology is improving diagnostic accuracy and efficiency, while multi-omics profiling approaches are enabling more comprehensive molecular characterization of gastric tumors. The ongoing shift toward minimally invasive and personalized diagnostic strategies is expected to accelerate adoption of novel testing modalities and drive market expansion.

• •Artificial intelligence and machine learning applications are being deployed in endoscopy and pathology to enhance detection sensitivity and reduce observer variability
• •Liquid biopsy technologies based on circulating tumor DNA and exosome analysis are anticipated to gain broader clinical acceptance for non-invasive monitoring
• •Healthcare system priorities toward earlier detection and personalized treatment regimens are expected to sustain demand for advanced gastric cancer diagnostics through the forecast period